Healthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Read articleHealthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Read articleThe contract pharma market is reshaping around scale, specialization, and regulatory trust. Swiss and DACH-based CROs/CDMOs are drawing strong inve...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read article